Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Revolutionizing Autoimmune Therapy: Antigen Specific Immunotherapy for Rheumatoid Arthritis with Virus Nanoparticles

Project description

Clinical trials of a potential cure for autoimmune diseases

In autoimmune diseases, the body’s immune system mistakenly targets its own healthy cells, tissues and organs, causing inflammation and damage. There is currently no cure for autoimmune diseases that are increasing in incidence globally. The Italian SME DIAMANTE develops plant-based peptide drugs. With the EIC-funded DIAMANTE project, the company aims to pursue clinical testing of its patented virus nanoparticles for antigen-specific immunotherapy. The virus nanoparticles have been shown to re-educate the immune system to tolerate the body’s antigens in animal models of rheumatoid arthritis. The treatment will be the first based on the restoration of self-tolerance while maintaining the immune system’s ability to defend itself against foreign threats.

Objective

At Diamante Società Benefit srl we leverage our proprietary Plant Molecular Farming Platform to develop cutting-edge treatments for autoimmune diseases through virus nanoparticles (VNP). Our patented protected VNPs’ mode of action is based on Antigen Specific Immunotehrapy. This means that our VNPs are able to re-educate the immune system to immune tolerate the specific body’s own cell (autoantigen) causing the disease. Our Proof-of-concept studies in Rheumatoid Arthritis (RA - our first indication) animal models have shown complete remission of arthritic symptoms. Currently, there is no cure or preventive measure for this chronic condition; first-line treatments revolve around immunosuppression, causing several side effects. Our drug will be the first treatment based on the restoration of self-tolerance, while maintaining the immune system’s ability to defend itself; hence reducing potential harmful side effects.
We are now seeking funding to cover the next clinical development steps.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC - HORIZON EIC Accelerator

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2024-ACCELERATOR-02

See all projects funded under this call

Coordinator

DIAMANTE SOCIETA BENEFIT S.R.L
Net EU contribution
€ 2 499 999,00
Address
STRADA LE GRAZIE 15
37134 Verona
Italy
SME
Yes
Region
Nord-Est Veneto Verona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data